Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Females and males, 18 years of older with overactive bladder symptoms~Exclusion Criteria:~* Treatable conditions that may cause urinary incontinence~* Medical conditions in which it would be unsafe to use an anti-cholinergic agent.~* The use of concomitant drugs that would confound the efficacy evaluation.~* The use of concomitant drugs that would be unsafe with an anti-cholinergic agent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oxybutynin topical gel (Type: EXPERIMENTAL): Oxybutynin topical gel
- Placebo topical gel (Type: PLACEBO_COMPARATOR): placebo topical gel

Based on this trial design, predict the completion outcome and termination type (if applicable).